Genetic and neural mechanisms shared by schizophrenia and depression
- PMID: 40175520
- DOI: 10.1038/s41380-025-02975-5
Genetic and neural mechanisms shared by schizophrenia and depression
Abstract
Schizophrenia (SCZ) and depression are two prevalent mental disorders characterized by comorbidity and overlapping symptoms, yet the underlying genetic and neural mechanisms remain largely elusive. Here, we investigated the genetic variants and neuroimaging changes shared by SCZ and depression in Europeans and then extended our investigation to cross-ancestry (Europeans and East Asians) populations. Using conditional and conjunctional analyses, we found 213 genetic variants shared by SCZ and depression in Europeans, of which 82.6% were replicated in the cross-ancestry population. The shared risk variants exhibited a higher degree of deleteriousness than random and were enriched for synapse-related functions, among which fewer than 3% of shared variants showed horizontal pleiotropy between the two disorders. Mendelian randomization analyses indicated reciprocal causal effects between SCZ and depression. Using multiple trait genetic colocalization analyses, we pinpointed 13 volume phenotypes shared by SCZ and depression. Particularly noteworthy were the shared volume reductions in the left insula and planum polare, which were validated through large-scale meta-analyses of previous studies and independent neuroimaging datasets of first-episode drug-naïve patients. These findings suggest that the shared genetic risk variants, synapse dysfunction, and brain structural changes may underlie the comorbidity and symptom overlap between SCZ and depression.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests. Ethics approval and consent to participate: All methods were performed in accordance with the relevant guidelines and regulations. Ethical approval for publicly available GWAS summary statistics was obtained from the respective ethics committees or institutional review boards, with informed consent obtained from participants in the original studies. For individual-level neuroimaging data, approval was granted by the Medical Ethical Committee of Tianjin Medical University General Hospital (IRB2018-179-01) and the First Psychiatric Hospital of Harbin (IRB2018-001), with informed consent obtained from all participants.
Similar articles
-
Multitrait Genetic Analysis Identifies Novel Pleiotropic Loci for Depression and Schizophrenia in East Asians.Schizophr Bull. 2025 May 8;51(3):684-695. doi: 10.1093/schbul/sbae145. Schizophr Bull. 2025. PMID: 39190819 Free PMC article.
-
A genome-wide cross-trait analysis characterizes the shared genetic architecture between lung and gastrointestinal diseases.Nat Commun. 2025 Mar 28;16(1):3032. doi: 10.1038/s41467-025-58248-w. Nat Commun. 2025. PMID: 40155373 Free PMC article.
-
Relationship Between Problematic Alcohol Use and Various Psychiatric Disorders: A Genetically Informed Study.Am J Psychiatry. 2025 Jul 1;182(7):671-682. doi: 10.1176/appi.ajp.20240095. Epub 2025 May 7. Am J Psychiatry. 2025. PMID: 40329641
-
Insights from Mendelian randomization and genetic correlation analyses into the relationship between endometriosis and its comorbidities.Hum Reprod Update. 2023 Sep 5;29(5):655-674. doi: 10.1093/humupd/dmad009. Hum Reprod Update. 2023. PMID: 37159502 Free PMC article. Review.
-
Pharmacological treatments in panic disorder in adults: a network meta-analysis.Cochrane Database Syst Rev. 2023 Nov 28;11(11):CD012729. doi: 10.1002/14651858.CD012729.pub3. Cochrane Database Syst Rev. 2023. PMID: 38014714 Free PMC article.
References
-
- Fava M, Kendler KS. Major depressive disorder. Neuron. 2000;28:335–41. - PubMed
-
- Ohayon MM, Schatzberg AF. Prevalence of depressive episodes with psychotic features in the general population. Am J Psychiatry. 2002;159:1855–61. - PubMed
-
- Hafner H, Maurer K, Trendler G, an der Heiden W, Schmidt M, Konnecke R. Schizophrenia and depression: challenging the paradigm of two separate diseases–a controlled study of schizophrenia, depression and healthy controls. Schizophr Res. 2005;77:11–24. - PubMed
-
- Buckley PF, Miller BJ, Lehrer DS, Castle DJ. Psychiatric comorbidities and schizophrenia. Schizophr Bull. 2009;35:383–402. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical